MediWales is the life science network for Wales, a not-for-profit, independent company that creates business opportunities and partnerships for our members. We support 180 members from the medical technology, diagnostic and pharmaceutical industries, NHS health boards, university departments and professional services and suppliers. We create collaboration through our popular programme of events that focus on strategic issues for the life science industry, including regulatory updates, market access, finance and funding, clinical unmet needs and international trade.

Organisation type
Gwyn Tudor

Nanna Therapeutics Ltd

Nanna Therapeutics has built a unique and game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Utilising its paradigm shift in the speed, efficiency and quality of drug discovery, as well as massively enhancing safety profiling to improve clinical success, Nanna Therapeutics is developing breakthrough medicines for the treatment of diseases that involve defects in mitochondrial function, such as MELAS and LHON, as well as diseases of the central nervous system, such as Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS).

Alexander Alanine
Chief Operating Officer 

National Institute for Health Research

The National Institute for Health Research (NIHR) is the most integrated clinical research system in the world, we drive research from bench to bedside for the benefit of patients and the economy under a number of themes by: - transforming research in the NHS - increasing the volume of applied health research for the benefit of patients and the public - driving faster translation of basic science discoveries into tangible benefits - developing and supporting the people who conduct and contribute to applied health research - attracting investment by the life sciences industry through our world-class facilities for health research.

Natalie Wilson
Business Development Manager 
Theo Christie
Business Development Manager 
Anjna Rising
Senior Business Development Manager 

Northern Health Science Alliance

The Northern Health Science Alliance Ltd is a membership organisation. Its board and council represent the leaders from the North's top research universities, research intensive teaching hospitals and Academic Health Science Networks. 

Organisation type
Ms Suzanne Ali-Hassan
Head of Corporate Engagement 
Mr Ben Martyn
Business Development Officer and Analyst 


OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our 380+ member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity - Europe's Leading Investment and Biopartnering Conference attracting over 1000 delegates (April 23-25, 2018).

Organisation type
Lee Pratley

One Nucleus

One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.

Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster. More than 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

Organisation type
Tony Jones

OxStem Limited

OxStem is a drug discovery company, spun-out from the University of Oxford, with the unique vision of developing in-situ cell programming therapies to treat what are typically (but certainly not exclusively) age-related conditions, such as Dementia, Heart Failure, Macular Degeneration (the leading cause of blindness in the developed world), Diabetes and Oncology.

The idea is straightforward – to use the Stem Cell and Medicinal Chemistry expertise within Chemistry and its associated partners at Oxford to identify new classes of drugs that can re-program or stimulate existing endogenous cells – awakening previously defunct or dormant cellular processes.

Dr Carolyn Porter
Chief Business Officer 
Dr Georg Terstappen

Peak Proteins

We tailor our professional services to fit your requirements, whatever stage of the process you are at.  From construct design, through to expression and purification of your desired protein. Whatever your end use, assay, high throughput screening, biophysics or crystallisation and X-ray structure determination, we can supply your protein in a suitable format.

Organisation type
Mark Abbott

Scottish Development International

At Scottish Development International (SDI) we’re all about discovery: helping ambitious businesses like yours discover an exciting new chapter in Scotland. We’re here to help you discover new business opportunities, markets, ventures and people. From tech to fintech to chemical science and digital technology, we’ve helped over 5135 inward investors to realise their ambitions in Scotland.

Mrs Katharina Kraehahn
Senior Executive 
Mrs Sofia NorĂ¥s
Senior Executive 

Therakind Ltd

Therakind, a private European pharmaceutical company, is focused on creating and developing safe, effective, authorised paediatric and speciality niche medicines. Our primary objective is to increase the availability of authorised paediatric and niche medicines and to ensure that the medication used today is both safe and effective.

Therakind's team has extensive experience in the paediatric pharmaceutical sector, we have the expertise to design clinical programmes and regulatory strategy to advance medicines from concept through to regulatory approval.

Susan Conroy
Chief Executive